PULMATRIX, INC. Prepaid Expense and Other Assets, Current
PULMATRIX, INC. (PULM) had Prepaid Expense and Other Assets, Current of $371.00 thousand as of 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-09-17
- 2026-06-30: Prepaid Expense and Other Assets, Current $371.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $465.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $41.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $178.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $371.00K S-4/A · filed 2026-09-17 | |
| 2026-03-31 | $465.00K S-4/A · filed 2026-08-03 | |
| 2025-12-31 | $41.00K S-4/A · filed 2026-09-17 | |
| 2025-09-30 | $178.00K 10-Q · filed 2025-10-16 | |
| 2025-06-30 | $317.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $317.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $399.00K S-4/A · filed 2026-09-17 | |
| 2024-09-30 | $641.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.20M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $712.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $742.00K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $899.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.02M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.15M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.07M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.91M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.14M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $1.96M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $871.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $938.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.60M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $962.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $723.00K 10-K · filed 2022-03-29 | $797.00K 10-K · filed 2021-03-23 |
| 2020-09-30 | $1.39M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.45M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $1.84M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $777.00K 10-K · filed 2021-03-23 | |
| 2019-09-30 | $960.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $1.11M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $1.24M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $717.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $914.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $619.00K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $346.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $696.00K 10-K · filed 2019-02-19 | |
| 2017-09-30 | $885.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $754.00K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $413.00K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $577.00K 10-K · filed 2018-03-13 | |
| 2016-09-30 | $1.02M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.01M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.01M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.56M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $1.33M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $510.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $166.00K 10-K · filed 2015-06-10 | |
| 2014-12-31 | $380.00K 10-K · filed 2016-03-10 | $199.00K 10-Q · filed 2015-02-13 |
| 2014-09-30 | $289.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $377.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $3.00K 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |